Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dyadic International, Inc. - Common Stock (NQ:DYAI)

0.9350 -0.0050 (-0.53%)
Streaming Delayed Price Updated: 2:12 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,119
Open 0.9249
Bid (Size) 0.9300 (4)
Ask (Size) 0.9399 (1)
Prev. Close 0.9400
Today's Range 0.9200 - 0.9399
52wk Range 0.9257 - 2.200
Shares Outstanding 28,811,061
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
From Dyadic International, Inc.
Via GlobeNewswire

Performance

YTD
-46.3%
-46.3%
1 Month
-10.1%
-10.1%
3 Month
-33.2%
-33.2%
6 Month
-37.2%
-37.2%
1 Year
-52.5%
-52.5%

More News

Read More
Dyadic to Present at World Vaccine Congress | Washington
From Dyadic International, Inc.
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga
Exploring Dyadic International's Earnings Expectations
Via Benzinga
Earnings Scheduled For May 14, 2025
Via Benzinga
Power Nickel (TSX.V: PNPN) – Undervalued Precious, Battery, Energy and Base Metals Play Amidst Gold Surge – More Stocks Inside
Via AB Newswire
Earnings Scheduled For March 26, 2025
Via Benzinga
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant to Advance Global Vaccines & Therapeutics with C1 Fungal Platform – More Stocks Inside
Via AB Newswire
Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
From Dyadic International, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic to Attend Multiple Industry Events in March
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Expands Global Presence with Participation in Key Industry Events
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
From Dyadic International, Inc.
Via GlobeNewswire
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
SmallCap Tech/Biotech Stocks July/Aug 2024: ZVSA, DYAI, ZVRA, PRSO, RLMD, VTAK, ENTO, INBS, KAVL
Via AB Newswire
Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS
Via AB Newswire
Dyadic Intl (NASDAQ: DYAI) and Proliant Health Biologicals to Launch $6 Billion Serum Albumin Market Product in 2025
Via AB Newswire
Topics Supply Chain
Exposures Supply Chain
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
From Dyadic International, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
Via AB Newswire
Topics Economy
Exposures Product Safety Supply Chain

Frequently Asked Questions

Is Dyadic International, Inc. - Common Stock publicly traded?
Yes, Dyadic International, Inc. - Common Stock is publicly traded.
What exchange does Dyadic International, Inc. - Common Stock trade on?
Dyadic International, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dyadic International, Inc. - Common Stock?
The ticker symbol for Dyadic International, Inc. - Common Stock is DYAI on the Nasdaq Stock Market
What is the current price of Dyadic International, Inc. - Common Stock?
The current price of Dyadic International, Inc. - Common Stock is 0.9350
When was Dyadic International, Inc. - Common Stock last traded?
The last trade of Dyadic International, Inc. - Common Stock was at 06/16/25 02:12 PM ET
What is the market capitalization of Dyadic International, Inc. - Common Stock?
The market capitalization of Dyadic International, Inc. - Common Stock is 26.94M
How many shares of Dyadic International, Inc. - Common Stock are outstanding?
Dyadic International, Inc. - Common Stock has 27M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.